Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer
Clinical trial NCT01579188 · UNKNOWN
Trial details
- NCT number
- NCT01579188
- Sponsor
- Kael-GemVax Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2016-05-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.